ClinicalTrials.govpublic full text
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
hepatitis c, tmc435-tidp16-c213, tmc435-c213, tmc435, hcv, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 993049
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.